Skip to main content
Premium Trial:

Request an Annual Quote

Alex Zrolka, Stan Letovsky, Kevin Sayer

Premium
Invetech has named Alex Zrolka vice president of business development for the company’s North American life sciences division, the firm said last week.
 
Zrolka previously worked in marketing management, business development, and sales for Biotech Envoy, Genicon Sciences, Qiagen, Bio-Rad Laboratories, and DNAStar.
 

 
Codon Devices has named Stan Letovsky executive director of bioinformatics and information technology, the company said last week.
 
Letovsky most recently was senior director of computational sciences at Millennium Pharmaceuticals.
 
He also was in global bioinformatics with Monsanto and worked on the Genome Database Project at Johns Hopkins Medical Institute.   
 

 
Kevin Sayer will join the board of directors at Eksigent, the company said last week.
 
Sayer, a biotech and pharmaceutical industry consultant, was named to the board as part of the company’s expansion of its medical devices segment, Eksigent said.

Filed under

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.